Cargando…

Opinion: why the variation in breast cancer survival in Europe?

Detalles Bibliográficos
Autor principal: Coleman, Michel P
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 1999
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC138506/
https://www.ncbi.nlm.nih.gov/pubmed/11250678
http://dx.doi.org/10.1186/bcr8
_version_ 1782120465292066816
author Coleman, Michel P
author_facet Coleman, Michel P
author_sort Coleman, Michel P
collection PubMed
description
format Text
id pubmed-138506
institution National Center for Biotechnology Information
language English
publishDate 1999
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-1385062003-02-27 Opinion: why the variation in breast cancer survival in Europe? Coleman, Michel P Breast Cancer Res Commentary BioMed Central 1999 1999-10-07 /pmc/articles/PMC138506/ /pubmed/11250678 http://dx.doi.org/10.1186/bcr8 Text en Copyright © 1999 Current Science Ltd
spellingShingle Commentary
Coleman, Michel P
Opinion: why the variation in breast cancer survival in Europe?
title Opinion: why the variation in breast cancer survival in Europe?
title_full Opinion: why the variation in breast cancer survival in Europe?
title_fullStr Opinion: why the variation in breast cancer survival in Europe?
title_full_unstemmed Opinion: why the variation in breast cancer survival in Europe?
title_short Opinion: why the variation in breast cancer survival in Europe?
title_sort opinion: why the variation in breast cancer survival in europe?
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC138506/
https://www.ncbi.nlm.nih.gov/pubmed/11250678
http://dx.doi.org/10.1186/bcr8
work_keys_str_mv AT colemanmichelp opinionwhythevariationinbreastcancersurvivalineurope